LY-377604

DB12858InvestigationalSmall molecule

Ly377604 has been used in trials studying the treatment of Obesity.

Mechanism: Pharmacologically active on Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, and Beta-3 adrenergic receptor
Curator reviewed
Formula / weight: C₃₁H₃₂N₄O₄ · 524.621 g/mol (avg)
Code names: LY-377604

Resolves to

Compound

Structure

InChIKeyRBSGUQYXRDKPAE-QFIPXVFZSA-NSMILESCC(C)(CC1=CC=C(OC2=CC=C(C=N2)C(N)=O)C=C1)NC[C@H](O)COC1=CC=CC2=C1C1=C(N2)C=CC=C1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with LY-377604, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.